Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
- Assessment of safety and tolerability of imatinib mesylate 400 mg bid in the clinical setting of peripheral T-cell lymphomas PTCL ; - Assessment of clinical responses defined as disease stabilization DS , partial remission PR , and complete remission CR .
Critère d'inclusion
- PERIPHERAL T-CELL LYMPHOMA PTCL EXPRESSING PDGFRA